The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
about
Comprehensive Dissection of Transcriptome Data and Regulatory Factors in Pancreatic Cancer Cells.Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types.An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells.Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.The Emerging Role of Zfp217 in Adipogenesis.ZNF217/ZFP217 Meets Chromatin and RNA.The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance.Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival.Downregulated miRNA-1269a variant (rs73239138) decreases the susceptibility to gastric cancer via targeting ZNF70.Molecular alterations associated with chronic exposure to cigarette smoke and chewing tobacco in normal oral keratinocytes.Zinc finger proteins orchestrate active gene silencing during embryonic stem cell differentiation.
P2860
Q36344287-CDBCA927-3E80-4572-92E3-CBE09B42E675Q37259845-2977C506-3480-40E2-9514-02522FA79EEFQ37268606-0144FAA1-A715-4D32-B085-B4E22EE1A1FAQ37649999-0085D78B-E0E4-4E37-9965-3089AB402848Q37705831-F40BDDEE-6F04-46BA-A160-4FAFBFD1E76DQ37709040-FA4DEE82-B663-4D35-A915-258B9D6BB23AQ38707300-D5EEBB32-A54A-4728-B210-0D8B9415E37FQ45245581-7FFD1DD6-E266-4B75-9E39-4DF89EB36BFFQ47415861-AAF481DF-5AD5-475C-A9B8-C406075B3C6BQ48200743-93EFD718-EC17-406B-AD91-9C6DD4D8D2EFQ49194577-5DFC238F-293A-4AC1-9B95-3BA28A30A3B0Q53069153-93F2A9D8-6122-42D4-885F-49EDD426CAB6Q54679268-AFD694A9-9170-462F-8E94-7008F14E3EB9
P2860
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@ast
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@en
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@nl
type
label
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@ast
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@en
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@nl
prefLabel
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@ast
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@en
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
@en
P2093
Hubert Lincet
Julie A Vendrell
Nhan T Nguyen
Pascale A Cohen
P2860
P304
41566-41581
P3181
P356
10.18632/ONCOTARGET.5893
P407
P5008
P577
2015-12-08T00:00:00Z